Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | {| class="wikitable sortable" | ||
! Drug Class | |||
! Drug | |||
! Initial daily dose, target dose (mg) | |||
! Preferred use | |||
! Preferably combined with | |||
|- | |||
| [[Thiazide diuretics]] || [[Chlorthalidone]] || 12.5, 12.5-25|| [[Heart failure]], [[systolic hypertension|isolated systolic hypertension]], black population|| [[ACE inhibitors]], [[ARBs]], [[calcium channel blockers]] | |||
|- | |||
| || [[Hydrochlorothiazide]] || 12.5-25, 25-100 | |||
|- | |||
| || [[Bendroflumethiazide]] || 5, 10 | |||
|- | |||
| || [[Indapamide]] || 1.25, 1.25-2.5 | |||
|- | |||
| [[ACE inhibitors]] || [[Enalapril]] || 5, 20|| [[Left ventricular hypertrophy]], [[atherosclerosis]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[peripheral artery disease]], [[metabolic syndrome]], [[diabetes mellitus]]|| [[Calcium channel blockers]], [[thiazide diuretics]] | |||
|- | |||
| || [[Lisinopril]] || 10, 40 | |||
|- | |||
| || [[Captopril]] || 50, 150-200 | |||
|- | |||
| [[ARBs]] || [[Candesartan]] || 4, 12-32|| [[Left ventricular hypertrophy]], [[renal insufficiency]], previous [[myocardial infarction]], [[heart failure]], [[atrial fibrillation]] (prevention), [[metabolic syndrome]], [[diabetes mellitus]]|| [[Calcium channel blockers]], [[thiazide diuretics]] | |||
|- | |||
| || [[Losartan]] || 50, 100 | |||
|- | |||
| || [[Valsartan]] || 40-80, 160-320 | |||
|- | |||
| || [[Eprosartan]] || 400, 600-800 | |||
|- | |||
| || [[Irbesartan]] || 75, 300 | |||
|- | |||
| [[Beta blockers]] || [[Atenolol]] || 25-50, 100|| Previous [[myocardial infarction]], [[atrial fibrillation]] (prevention and ventricular rate control), [[heart failure]], [[Chronic stable angina|angina pectoris]], [[aortic aneurysm]], [[pregnancy]]|| [[Thiazide diuretics]] (with limitations)<br>'''Only [[Calcium channel blocker#Dihydropyridine|dihydropyridine calcium channel blockers]] should be combined with [[beta blockers]]''' | |||
|- | |||
| || [[Metoprolol succinate]] || 50, 100-200 | |||
|- | |||
| [[Calcium channel blockers]]|| [[Amlodipine]] || 2.5, 10|| [[Left ventricular hypertrophy]], [[pregnancy]] ([[nifedipine]]), previous [[myocardial infarction]], [[atrial fibrillation]] ([[verapamil]], [[diltiazem]]), [[metabolic syndrome]], [[peripheral artery disease]], [[atherosclerosis]], [[Chronic stable angina|angina pectoris]], [[systolic hypertension|isolated systolic hypertension]], black population|| [[ACE inhibitors]], [[ARBs]], [[thiazide diuretics]] | |||
|- | |||
| || [[Diltiazem extended release]] || 120-180, 360 | |||
|- | |||
| || [[Nitrendipine]] || 10, 20 | |||
|- | |||
|} |